Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

1.53
-0.0050-0.33%
Volume:150.61K
Turnover:227.65K
Market Cap:92.37M
PE:-0.67
High:1.55
Open:1.52
Low:1.47
Close:1.53
52wk High:3.36
52wk Low:0.8551
Shares:60.57M
Float Shares:32.93M
Volume Ratio:0.59
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2658
EPS(LYR):-1.7051
ROE:-75.71%
ROA:-39.06%
PB:0.79
PE(LYR):-0.89

Loading ...

Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Correspondence

Form CORRESP - Correspondence
Mar 27, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities